Mighty Max getting stronger & growing nearly a year after receiving Zolgensma
It has been just over one year since the Alberta government announced it will begin funding the drug Zolgensma on a case-by-case basis for those suffering from Spinal Muscular Atrophy (SMA).
Zolgensma is a gene therapy replacement drug that can help people who are suffering from SMA.
SMA is a rare neuromuscular disorder and results in the loss of motor neurons and progressive muscle wasting. The disease makes it tough for children to grow muscles as they get older.
Fairview’s Mighty Max Sych was approved to receive funding for the drug towards the end of February 2020 and it was administered at the Stollery Children’s Hospital in Edmonton on March 16.